A nationwide cohort study on Creutzfeldt-Jakob disease among human growth hormone recipients

Neuroepidemiology

Volumn 19, Issue 4, 2000, Pages 201-205

  Wientjens, D P W M ^a   Rikken, B ^b   Wit, J M ^b,c   Hofman, A ^a   Stricker, B H Ch ^a,d  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d Drug Safety Unit   (Netherlands)

Author keywords

Cohort study; Creutzfeldt Jakob disease; Human derived growth hormone; Pharmaco epidemiology; Record linkage studies

Indexed keywords

HUMAN GROWTH HORMONE;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; CREUTZFELDT JAKOB DISEASE; DISEASE TRANSMISSION; HISTOGRAM; HUMAN; MAJOR CLINICAL STUDY; NETHERLANDS; PHARMACOEPIDEMIOLOGY; PRION DISEASE; RETROSPECTIVE STUDY;

EID: 0033933995     PISSN: 02515350     EISSN: None     Source Type: Journal    
DOI: 10.1159/000026256     Document Type: Article

References (22)

1. Collinge J, Palmer MS: Molecular genetics of human prion diseases. Philos Trans R Soc Lond B Biol Sci 1994;343:371-378.
2. Masters CL, Richardson EP Jr: Sub-acute spongiform encephalopathy Creutzfeldt-Jakob disease: The nature and progression of spongiform change. Brain 1978;101:333-344.
3. Will RG, Matthews WB: Evidence for case-to-case transmission of Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry 1982;45:235-238.
4. Thadani V, Penar PL, Partington J, et al: Creutzfeldt-Jakob disease probably acquired from a cadaveric dura mater graft. J Neurosurg 1988; 69:766-769.
5. Bernouilli C, Siegfried J, Baumgartner G, et al: Danger of accidental person to person transmission of Creutzfeldt-Jakob disease by surgery. Lancet 1977;i:478-479.
6. Duffy P, Wolf J, Collins G, et al: Possible person to person transmission of Creutzfeldt-Jakob disease. N Engl J Med 1974;290:692-693.
7. Powell-Jackson J, Weller RO, Kennedy P, et al: Creutzfeldt-Jakob disease after administration of human growth hormone. Lancet 1985;ii: 244-246.
8. Gibbs CJ, Joy A, Heffner R, et al: Clinical and pathological features and laboratory confirmation of Creutzfeldt-Jakob disease in a recipient of pituitary-derived human growth hormone. N Engl J Med 1985;313:734-739.
9. Brown P, Gajdusek DC, Gibbs CJ, et al: Potential epidemic of Creutzfeldt-Jakob disease from human growth hormone therapy. N Engl J Med 1985;313:728-731.
10. Cochius JI, Mack K, Burns RJ, et al: Creutzfeldt-Jakob disease in a recipient of human pituitary gonadotrophin. Aust NZ J Med 1990;20:592-593.
11. Will RG, Ironside JW, Zeidler M, Cousens SN, Estibeiro K, Alpérovitch A, et al: A new variant of Creutzfeldt-Jakob disease in the UK. Lancet 1996;347:921-925.
12. Bruce ME, Will RG, Ironside JW, McConnell I, Drummond D, Suttle A, et al: Transmission to mice indicate that 'new variant' CJD is caused by the BSE agent. Nature 1997;389:498-501.
13. Van Duijn CM, Delasnerie-Lauprêtre N, Masullo C, et al: Case-control study of risk factors of Creutzfeldt-Jakob disease in Europe during 1993-1995. Lancet 1998;351:1081-1085.
14. Koch TK, Berg BO, DeArmond SJ, Gravina RF: Creutzfeldt-Jakob disease in a young adult with idiopathic hypopituitarism. N Eng J Med 1985;313:731-733.
15. Steendijk R, Stoclinga GBA: Groeihormoon en de ziekte van Creutzfeldt-Jakob. Ned Tijdschr Geneeskd 1985;129:1101-1102.
16. Roos RAC, Wintzen AR, Will RG, Ironside J, van Duinen SG: Een patient met de ziekte van Creutzfeldt-Jakob na behandeling met humaan groeihormoon. Ned Tijdschr Geneeskd 1996;140:1190-1193.
17. Rikken B, Massa G, Wit JM, van den Brande JL: Hypofysair groeihormoon en de ziekte van Creutzfeldt-Jakob in Nederland. Ned Tijdschr Geneeskd 1996;140:1163-1165.
18. Registratiekamer: Gedragscode gezondheidsonderzoek; verklaring van overeenstemming inzake de gedragscode. Staatscourant 140, 24 juli 1995.
19. Brown P, Cathala F, Raubertas RF, et al: The epidemiology of Creutzfeldt-Jakob disease: Conclusion of a 15-year investigation in France and review of the world literature. Neurology 1987;37:895-904.
20. Brown P, Preece M, Will RG: 'Friendly fire' in medicine: Hormones, homografts, and Creutzfeldt-Jakob disease. Lancet 1992; 340:24-27.
21. Buchanan CR, Preece MA, Milner RDG: Mortality, neoplasma, and Creutzfeldt-Jakob disease in patients treated with human pituitary growth hormone in the United Kingdom. Br Med J 1991;302:824-828.
22. Billetes de Villemuir T, Deslys J-P, Pradel A, Soubrié C, Alpérovitch A, Tardieu M, Chaussin J-L, Hauw J-J, Dormont D, Ruberg M, Agid Y: Creutzfeldt-Jakob disease from contaminated growth hormone extracts in France. Neurology 1996;47:690-695.